Inventor
MUCHHAL UMESH
US22 patents
⚠️ This page may combine multiple inventors who share the name “MUCHHAL UMESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
19 patentsUS9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10526417B2Jan 7, 2020
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC27 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US7244823B2Jul 17, 2007
TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
XENCOR INC49 citations90
US7144987B1Dec 5, 2006
Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
XENCOR INC23 citations88
US11945880B2Apr 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11859011B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11352442B2Jun 7, 2022
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC2 citations73
US10913803B2Feb 9, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10889653B2Jan 12, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC2 citations73
US12359002B2Jul 15, 2025
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12152076B2Nov 26, 2024
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
XENCOR INC0 citations62
US12129309B2Oct 29, 2024
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC0 citations62
US11673972B2Jun 13, 2023
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US11312770B2Apr 26, 2022
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
XENCOR INC1 citations62
US11111315B2Sep 7, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US7071307B2Jul 4, 2006
Nucleic acids and proteins with thioredoxin reductase activity
XENCOR INC3 citations60